nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Neuropathy—Sorafenib—liver cancer	0.032	0.0346	CcSEcCtD
Procaine—Dermatitis exfoliative—Sorafenib—liver cancer	0.0262	0.0283	CcSEcCtD
Procaine—Clomifene—ESR1—liver cancer	0.0245	0.333	CrCbGaD
Procaine—Eruption—Epirubicin—liver cancer	0.0205	0.0221	CcSEcCtD
Procaine—Clomifene—CYP2E1—liver cancer	0.0199	0.27	CrCbGaD
Procaine—Clomifene—CYP1A1—liver cancer	0.0196	0.266	CrCbGaD
Procaine—Eruption—Doxorubicin—liver cancer	0.019	0.0205	CcSEcCtD
Procaine—Neuropathy peripheral—Sorafenib—liver cancer	0.0187	0.0202	CcSEcCtD
Procaine—Paralysis—Epirubicin—liver cancer	0.0181	0.0196	CcSEcCtD
Procaine—Ventricular arrhythmia—Epirubicin—liver cancer	0.017	0.0184	CcSEcCtD
Procaine—Paralysis—Doxorubicin—liver cancer	0.0168	0.0181	CcSEcCtD
Procaine—Tinnitus—Sorafenib—liver cancer	0.016	0.0172	CcSEcCtD
Procaine—Ventricular arrhythmia—Doxorubicin—liver cancer	0.0158	0.017	CcSEcCtD
Procaine—Erythema—Sorafenib—liver cancer	0.0149	0.0161	CcSEcCtD
Procaine—Vasodilation procedure—Epirubicin—liver cancer	0.0143	0.0155	CcSEcCtD
Procaine—Vasodilation—Epirubicin—liver cancer	0.0143	0.0155	CcSEcCtD
Procaine—Angioedema—Sorafenib—liver cancer	0.0136	0.0147	CcSEcCtD
Procaine—Syncope—Sorafenib—liver cancer	0.0134	0.0144	CcSEcCtD
Procaine—Leukopenia—Sorafenib—liver cancer	0.0133	0.0144	CcSEcCtD
Procaine—Vasodilation procedure—Doxorubicin—liver cancer	0.0133	0.0143	CcSEcCtD
Procaine—Vasodilation—Doxorubicin—liver cancer	0.0133	0.0143	CcSEcCtD
Procaine—Loss of consciousness—Sorafenib—liver cancer	0.0131	0.0142	CcSEcCtD
Procaine—Atrioventricular block—Epirubicin—liver cancer	0.013	0.014	CcSEcCtD
Procaine—Hypertension—Sorafenib—liver cancer	0.0129	0.0139	CcSEcCtD
Procaine—Arthralgia—Sorafenib—liver cancer	0.0127	0.0137	CcSEcCtD
Procaine—Anaphylactic shock—Sorafenib—liver cancer	0.0122	0.0131	CcSEcCtD
Procaine—Atrioventricular block—Doxorubicin—liver cancer	0.012	0.013	CcSEcCtD
Procaine—Shock—Sorafenib—liver cancer	0.012	0.0129	CcSEcCtD
Procaine—Thrombocytopenia—Sorafenib—liver cancer	0.0119	0.0129	CcSEcCtD
Procaine—Neuropathy—Epirubicin—liver cancer	0.0118	0.0128	CcSEcCtD
Procaine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.0111	0.012	CcSEcCtD
Procaine—Neuropathy—Doxorubicin—liver cancer	0.011	0.0118	CcSEcCtD
Procaine—Fatigue—Sorafenib—liver cancer	0.0105	0.0113	CcSEcCtD
Procaine—Probenecid—ALB—liver cancer	0.00971	0.132	CrCbGaD
Procaine—Dermatitis exfoliative—Epirubicin—liver cancer	0.0097	0.0105	CcSEcCtD
Procaine—Urticaria—Sorafenib—liver cancer	0.00967	0.0104	CcSEcCtD
Procaine—Body temperature increased—Sorafenib—liver cancer	0.00962	0.0104	CcSEcCtD
Procaine—Anaphylactoid reaction—Epirubicin—liver cancer	0.00946	0.0102	CcSEcCtD
Procaine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00897	0.00969	CcSEcCtD
Procaine—Hypersensitivity—Sorafenib—liver cancer	0.00897	0.00968	CcSEcCtD
Procaine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00875	0.00945	CcSEcCtD
Procaine—Cardiac arrest—Epirubicin—liver cancer	0.0087	0.0094	CcSEcCtD
Procaine—Pruritus—Sorafenib—liver cancer	0.00861	0.0093	CcSEcCtD
Procaine—Diarrhoea—Sorafenib—liver cancer	0.00833	0.00899	CcSEcCtD
Procaine—Cardiac arrest—Doxorubicin—liver cancer	0.00805	0.00869	CcSEcCtD
Procaine—Dizziness—Sorafenib—liver cancer	0.00805	0.00869	CcSEcCtD
Procaine—Eosinophilia—Epirubicin—liver cancer	0.00783	0.00846	CcSEcCtD
Procaine—Vomiting—Sorafenib—liver cancer	0.00774	0.00835	CcSEcCtD
Procaine—Rash—Sorafenib—liver cancer	0.00767	0.00829	CcSEcCtD
Procaine—Dermatitis—Sorafenib—liver cancer	0.00767	0.00828	CcSEcCtD
Procaine—Eosinophilia—Doxorubicin—liver cancer	0.00725	0.00782	CcSEcCtD
Procaine—Nausea—Sorafenib—liver cancer	0.00723	0.00781	CcSEcCtD
Procaine—Drowsiness—Epirubicin—liver cancer	0.00705	0.00761	CcSEcCtD
Procaine—Neuropathy peripheral—Epirubicin—liver cancer	0.00691	0.00746	CcSEcCtD
Procaine—Drowsiness—Doxorubicin—liver cancer	0.00653	0.00705	CcSEcCtD
Procaine—Bradycardia—Epirubicin—liver cancer	0.00645	0.00696	CcSEcCtD
Procaine—Neuropathy peripheral—Doxorubicin—liver cancer	0.0064	0.00691	CcSEcCtD
Procaine—Bradycardia—Doxorubicin—liver cancer	0.00596	0.00644	CcSEcCtD
Procaine—Tinnitus—Epirubicin—liver cancer	0.0059	0.00637	CcSEcCtD
Procaine—Chills—Epirubicin—liver cancer	0.00568	0.00613	CcSEcCtD
Procaine—Erythema—Epirubicin—liver cancer	0.00551	0.00595	CcSEcCtD
Procaine—Tinnitus—Doxorubicin—liver cancer	0.00546	0.0059	CcSEcCtD
Procaine—Tension—Epirubicin—liver cancer	0.00541	0.00584	CcSEcCtD
Procaine—Nervousness—Epirubicin—liver cancer	0.00535	0.00578	CcSEcCtD
Procaine—Chills—Doxorubicin—liver cancer	0.00526	0.00567	CcSEcCtD
Procaine—Vision blurred—Epirubicin—liver cancer	0.00519	0.00561	CcSEcCtD
Procaine—Erythema—Doxorubicin—liver cancer	0.0051	0.00551	CcSEcCtD
Procaine—Agitation—Epirubicin—liver cancer	0.00506	0.00547	CcSEcCtD
Procaine—Tension—Doxorubicin—liver cancer	0.005	0.0054	CcSEcCtD
Procaine—Nervousness—Doxorubicin—liver cancer	0.00495	0.00535	CcSEcCtD
Procaine—Syncope—Epirubicin—liver cancer	0.00494	0.00534	CcSEcCtD
Procaine—Leukopenia—Epirubicin—liver cancer	0.00493	0.00533	CcSEcCtD
Procaine—Loss of consciousness—Epirubicin—liver cancer	0.00484	0.00523	CcSEcCtD
Procaine—Vision blurred—Doxorubicin—liver cancer	0.00481	0.00519	CcSEcCtD
Procaine—Convulsion—Epirubicin—liver cancer	0.00478	0.00516	CcSEcCtD
Procaine—Hypertension—Epirubicin—liver cancer	0.00476	0.00514	CcSEcCtD
Procaine—Arthralgia—Epirubicin—liver cancer	0.00469	0.00507	CcSEcCtD
Procaine—Agitation—Doxorubicin—liver cancer	0.00469	0.00506	CcSEcCtD
Procaine—Anxiety—Epirubicin—liver cancer	0.00468	0.00505	CcSEcCtD
Procaine—Syncope—Doxorubicin—liver cancer	0.00457	0.00494	CcSEcCtD
Procaine—Leukopenia—Doxorubicin—liver cancer	0.00456	0.00493	CcSEcCtD
Procaine—Anaphylactic shock—Epirubicin—liver cancer	0.0045	0.00486	CcSEcCtD
Procaine—Oedema—Epirubicin—liver cancer	0.0045	0.00486	CcSEcCtD
Procaine—Loss of consciousness—Doxorubicin—liver cancer	0.00448	0.00484	CcSEcCtD
Procaine—Shock—Epirubicin—liver cancer	0.00443	0.00478	CcSEcCtD
Procaine—Convulsion—Doxorubicin—liver cancer	0.00442	0.00477	CcSEcCtD
Procaine—Thrombocytopenia—Epirubicin—liver cancer	0.0044	0.00475	CcSEcCtD
Procaine—Hypertension—Doxorubicin—liver cancer	0.0044	0.00475	CcSEcCtD
Procaine—Tachycardia—Epirubicin—liver cancer	0.00439	0.00474	CcSEcCtD
Procaine—Hyperhidrosis—Epirubicin—liver cancer	0.00435	0.00469	CcSEcCtD
Procaine—Arthralgia—Doxorubicin—liver cancer	0.00434	0.00469	CcSEcCtD
Procaine—Anxiety—Doxorubicin—liver cancer	0.00433	0.00467	CcSEcCtD
Procaine—Hypotension—Epirubicin—liver cancer	0.0042	0.00454	CcSEcCtD
Procaine—Anaphylactic shock—Doxorubicin—liver cancer	0.00416	0.00449	CcSEcCtD
Procaine—Oedema—Doxorubicin—liver cancer	0.00416	0.00449	CcSEcCtD
Procaine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.0041	0.00442	CcSEcCtD
Procaine—Shock—Doxorubicin—liver cancer	0.00409	0.00442	CcSEcCtD
Procaine—Thrombocytopenia—Doxorubicin—liver cancer	0.00408	0.0044	CcSEcCtD
Procaine—Tachycardia—Doxorubicin—liver cancer	0.00406	0.00439	CcSEcCtD
Procaine—Hyperhidrosis—Doxorubicin—liver cancer	0.00402	0.00434	CcSEcCtD
Procaine—Somnolence—Epirubicin—liver cancer	0.004	0.00432	CcSEcCtD
Procaine—Hypotension—Doxorubicin—liver cancer	0.00389	0.0042	CcSEcCtD
Procaine—Fatigue—Epirubicin—liver cancer	0.00388	0.00419	CcSEcCtD
Procaine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00379	0.00409	CcSEcCtD
Procaine—Somnolence—Doxorubicin—liver cancer	0.0037	0.00399	CcSEcCtD
Procaine—Fatigue—Doxorubicin—liver cancer	0.00359	0.00387	CcSEcCtD
Procaine—Urticaria—Epirubicin—liver cancer	0.00357	0.00386	CcSEcCtD
Procaine—Body temperature increased—Epirubicin—liver cancer	0.00356	0.00384	CcSEcCtD
Procaine—Hypersensitivity—Epirubicin—liver cancer	0.00331	0.00358	CcSEcCtD
Procaine—Urticaria—Doxorubicin—liver cancer	0.00331	0.00357	CcSEcCtD
Procaine—Body temperature increased—Doxorubicin—liver cancer	0.00329	0.00355	CcSEcCtD
Procaine—Pruritus—Epirubicin—liver cancer	0.00318	0.00344	CcSEcCtD
Procaine—Diarrhoea—Epirubicin—liver cancer	0.00308	0.00332	CcSEcCtD
Procaine—Hypersensitivity—Doxorubicin—liver cancer	0.00307	0.00331	CcSEcCtD
Procaine—Dizziness—Epirubicin—liver cancer	0.00297	0.00321	CcSEcCtD
Procaine—Pruritus—Doxorubicin—liver cancer	0.00294	0.00318	CcSEcCtD
Procaine—Vomiting—Epirubicin—liver cancer	0.00286	0.00309	CcSEcCtD
Procaine—Diarrhoea—Doxorubicin—liver cancer	0.00285	0.00307	CcSEcCtD
Procaine—Rash—Epirubicin—liver cancer	0.00284	0.00306	CcSEcCtD
Procaine—Dermatitis—Epirubicin—liver cancer	0.00283	0.00306	CcSEcCtD
Procaine—Dizziness—Doxorubicin—liver cancer	0.00275	0.00297	CcSEcCtD
Procaine—Nausea—Epirubicin—liver cancer	0.00267	0.00288	CcSEcCtD
Procaine—Vomiting—Doxorubicin—liver cancer	0.00265	0.00286	CcSEcCtD
Procaine—Rash—Doxorubicin—liver cancer	0.00262	0.00283	CcSEcCtD
Procaine—Dermatitis—Doxorubicin—liver cancer	0.00262	0.00283	CcSEcCtD
Procaine—Nausea—Doxorubicin—liver cancer	0.00247	0.00267	CcSEcCtD
